NCT05664074: A reported trial by David Vitale MD
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT05664074 |
|---|---|
| Title | Post ERCP Pancreatitis Prophylaxis, Effectiveness of Rectal Indomethacin vs Intravenous Ketorolac in the Pediatric Population |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 7, 2022 |
| Completion date | Feb. 5, 2025 |
| Required reporting date | Feb. 5, 2026, midnight |
| Actual reporting date | Feb. 5, 2026 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |